In addition, berberine is another antioxidant that inhibits the development of colitis-associated colorectal cancer by interfering with TNFα and IL-6-induced inflammatory responses in colonic macrophages, thereby inhibiting EGFR/ERK signaling in tumor cells [175]. This evidence concerns the gene IL6 and colitis.